Table 1.
N | References | Country | Ethnicity | Genotyping Method | Design |
Cases/ Controls |
Genotype distributiona | Cancer Type | Quality Score | PHWE | |
---|---|---|---|---|---|---|---|---|---|---|---|
Cases | Controls | ||||||||||
1 | Abdel-Hamid et al., 2018 | Egypt | African | PCR-RFLP | PB | 50/50 | 21/26/3 | 24/20/6 | HCC | 10 | 0.53 |
2 | Damodaran et al., 2018 | India | Asian | PCR-RFLP | HB | 100/100 | 32/51/17 | 47/36/17 | PC | 7 | 0.054 |
3 | Doulah et al., 2018 | Iran | Asian | ARMS-PCR | HB | 98/100 | 33/51/14 | 25/62/13 | BC | 3 | 0.015 |
4 | He J. et al., 2018 | China | Asian | TaqMan | HB | 393/812 | 94/192/107 | 183/399/230 | NB | 11 | 0.73 |
5 | Mashayekhi et al., 2018 | Iran | Asian | PCR-RFLP | HB | 353/353 | 142/169/42 | 149/158/46 | BC | 10 | 0.75 |
6 | Minh et al., 2018 | Vietnam | Vietnamese | HRMA | HB | 113/127 | 48/35/30 | 31/64/32 | BC | 5 | 0.95 |
7 | Afsharzadeh et al., 2017 | Iran | Asian | ARMS-PCR | Not mentioned | 100/150 | 34/52/14 | 38/93/19 | BC | 3 | 0.002 |
8 | Bodal et al., 2017 | India | Asian | PCR-RFLP | HB | 95/99 | 48/47/0 | 64/35/0 | BC | 8 | 0.051 |
9 | Huang et al., 2017 | China | Asian | PCR-RFLP | PB | 165/284 | 22/81/62 | 39/134/111 | HCC | 9 | 0.95 |
10 | Poltronieri-Oliveira et al., 2017 | Brazil | Mixed | PCR-RFLP | PB | 149/246 | 64/57/28 | 105/120/21 | GC | 9 | 0.12 |
11 | Rakmanee et al., 2017 | Thiland | Asian | PCR-RFLP | HB | 104/180 | 48/43/13 | 49/78/53 | ALL | 9 | 0.09 |
12 | Rogoveanu et al., 2017 | Romania | Caucasian | TaqMan | HB | 142/288 | 61/63/18 | 121/128/39 | GC | 9 | 0.64 |
13 | Srivastava et al., 2017 | India | Asian | PCR-RFLP | HB | 184/164 | 20/93/71 | 21/81/62 | CSCC | 1- | 0.57 |
14 | Yin et al., 2017 | China | Asian | TaqMan | HB | 1,003/1,003 | 252/555/196 | 221/496/286 | LC | 1- | 0.86 |
15 | Zhang E. et al., 2017 | China | Asian | TaqMan | HB | 340/340 | 71/169/100 | 88/155/97 | OC | 11 | 0.12 |
16 | Dai et al., 2016 | China | Asian | Mass-ARRAY | HB | 560/583 | 197/265/98 | 155/284/144 | BC | 10 | 0.58 |
17 | Gu and Tu, 2016 | China | Asian | PCR-RFLP | HB | 186/186 | 39/96/51 | 57/98/31 | GC | 7 | 0.36 |
18 | Hashemi et al., 2016 | Iran | Asian | t-ARMS-PCR | HB | 169/182 | 64/88/17 | 77/93/12 | PC | 7 | 0.029 |
19 | Li M. et al., 2016 | China | Asian | MassARRAY | HB | 182/182 | 24/83/75 | 11/79/92 | GC | 8 | 0.33 |
20 | Li J. et al., 2016 | China | Asian | Sequencing | Not mentioned | 109/105 | 25/64/20 | 18/52/35 | HCC | 8 | 0.95 |
21 | Miao et al., 2016 | China | Asian | Array (Illumina Infinium1) | HB | 576/1,550 | 130/284/162 | 292/755/503 | HNSCC | 12 | 0.80 |
22 | Morales et al., 2016 | Chile | Mixed | TaqMan | PB | 440/807 | 192/191/57 | 342/351/114 | BC | 12 | 0.13 |
23 | Ni and Huang, 2016 | China | Asian | PCR-RFLP | HB | 155/342 | 32/82/41 | 66/176/100 | OvC | 9 | 0.51 |
24 | Peckham-Gregory et al., 2016 | USA | Caucasian | Allele-specific PCR Array | PB | 179/529 | 72/88/19 | 196/257/76 | NHL | 13 | 0.62 |
25 | Shen et al., 2016 | China | Asian | SNaPshot | PB | 1,400/2,185 | 295/698/407 | 392/1121/672 | ESCC | 10 | 0.046 |
26 | Song et al., 2016 | China | Asian | PCR-RFLP | PB | 479/431 | 121/247/111 | 86/203/142 | OvC | 13 | 0.42 |
27 | Su et al., 2016 | China | Asian | PCR-RFLP | HB | 245/315 | 83/128/34 | 119/158/38 | GC | 10 | 0.22 |
28 | Sun et al., 2016 | China | Asian | PCR-RFLP | HB | 134/227 | 29/66/39 | 34/116/77 | OvC | 7 | 0.42 |
29 | Toraih et al., 2016b | Egypt | African | TaqMan | HB | 209/100 | 84/93/32 | 55/35/10 | Cancer | 8 | 0.30 |
30 | Toraih et al., 2016a | Egypt | African | TaqMan | PB | 125/150 | 48/63/14 | 80/53/17 | Cancer | 11 | 0.11 |
31 | Wang et al., 2017 | China | Asian | Mass-ARRAY | PB | 283/283 | 73/158/52 | 65/124/94 | BlC | 10 | 0.066 |
32 | Yin et al., 2016 | China | Asian | TaqMan | HB | 575/608 | 128/298/149 | 133/297/178 | LC | 14 | 0.70 |
33 | Zhang L. H. et al., 2016 | China | Asian | PCR-RFLP | PB | 175/302 | 25/85/65 | 42/138/122 | HCC | 9 | 0.83 |
34 | Zhao et al., 2016 | China | Asian | Sequencing | HB | 114/114 | 31/50/33 | 28/61/25 | BC | 9 | 0.53 |
35 | Zhou et al., 2011 | China | Asian | PCR-RFLP | HB | 226/309 | 46/123/57 | 58/169/82 | CSCC | 12 | 0.09 |
36 | Deng et al., 2015 | China | Asian | PCR-RFLP | PB | 159/298 | 41/66/52 | 56/166/76 | BlC | 9 | 0.048 |
37 | Dikaiakos et al., 2015 | Greece | Caucasian | PCR-RFLP | PB | 157/299 | 19/69/69 | 33/149/117 | CRC | 10 | 0.18 |
38 | He et al., 2015 | China | Asian | Mass-ARRAY | PB | 450/450 | 81/233/136 | 93/223/134 | BC | 11 | 0.94 |
39 | Li T. et al., 2015 | China | Asian | PCR-RFLP | PB | 318/320 | 61/146/111 | 42/134/144 | NHL | 13 | 0.26 |
40 | Liu, 2015 | China | Asian | PCR-RFLP | PB | 266/266 | 84/131/51 | 113/123/30 | HCC | 12 | 0.76 |
41 | Liu, 2015 | China | Asian | PCR-RFLP | HB | 216/100 | 25/133/58 | 23/49/28 | GyC | 5 | 0.95 |
42 | Martin-Guerrero et al., 2015 | Spain | Caucasian | TaqMan | PB | 104/345 | 35/40/29 | 137/159/49 | CLL | 9 | 0.86 |
43 | Nikolić et al., 2015 | Serbia | Caucasian | HRMA | PB | 351/309 | 150/161/40 | 121/147/41 | PC | 10 | 0.79 |
44 | Qi et al., 2015 | China | Asian | TaqMan | PB | 321/290 | 34/119/168 | 17/88/185 | BC | 11 | 0.18 |
45 | Sodhi et al., 2015 | India | Asian | PCR-RFLP | PB | 250/255 | 70/161/19 | 101/146/8 | LC | 12 | 5.46e−7 |
46 | Sushma et al., 2015 | India | Asian | PCR-RFLP | PB | 100/102 | 22/10/68 | 6/15/81 | OC | 8 | 0.001 |
47 | Yan et al., 2015 | China | Asian | PCR-RFLP | HB | 274/328 | 46/147/81 | 27/165/136 | HCC | 9 | 0.02 |
48 | Yin et al., 2015 | China | Asian | TaqMan | HB | 258/310 | 50/141/67 | 63/150/97 | LC | 11 | 0.78 |
49 | Bansal et al., 2014 | India | Asian | PCR-RFLP | PB | 121/165 | 68/41/12 | 85/59/21 | BC | 9 | 0.058 |
50 | Chu et al., 2014 | Taiwan | Asian | PCR-RFLP | PB | 188/337 | 41/81/66 | 70/167/100 | HCC | 12 | 0.94 |
51 | Dikeakos et al., 2014 | Greece | Caucasian | PCR-RFLP | HB | 163/480 | 102/46/15 | 79/229/172 | GC | 9 | 0.9 |
52 | Hao et al., 2014 | China | Asian | PCR-RFLP | PB | 235/282 | 77/126/32 | 67/160/55 | HCC | 11 | 0.027 |
53 | Kou et al., 2014 | China | Asian | PCR-RFLP | PB | 271/532 | 84/150/37 | 125/304/103 | HCC | 9 | 0.001 |
54 | Kupcinskas et al., 2014b | Latvia | Caucasian | TaqMan | HB | 363/350 | 144/184/35 | 159/145/46 | GC | 8 | 0.18 |
55 | Kupcinskas et al., 2014a | Latvia | Caucasian | TaqMan | HB | 193/427 | 79/87/27 | 199/174/54 | CRC | 8 | 0.12 |
56 | Li et al., 2014 | China | Asian | TaqMan | PB | 1,020/1,006 | 209/489/322 | 218/518/270 | NC | 13 | 0.32 |
57 | Du et al., 2014 | China | Asian | TaqMan | PB | 1,000/1,022 | 149/514/337 | 211/497/314 | RCC | 13 | 0.61 |
58 | Omrani et al., 2014 | Iran | Asian | T-ARMS-PCR | PB | 236/203 | 218/18/0 | 178/25/0 | BC | 11 | 0.70 |
59 | Parlayan et al., 2014 | Japan | Asian | TaqMan | HB | 827/524 | 174/409/244 | 108/270/146 | Cancer | 11 | 0.44 |
60 | Pu et al., 2014 | China | Asian | PCR-RFLP | HB | 159/511 | 39/95/25 | 101/324/86 | GC | 9 | 1.7e−9 |
61 | Qi et al., 2014 | China | Asian | HRMA | PB | 314/406 | 45/209/60 | 71/214/121 | HCC | 12 | 0.17 |
62 | Qu et al., 2014 | China | Asian | PCR-RFLP | PB | 381/426 | 126/207/48 | 133/211/82 | ESCC | 13 | 0.96 |
63 | Roy et al., 2014 | India | Asian | TaqMan | HB | 451/448 | 218/187/46 | 242/168/38 | OC | 10 | 0.29 |
64 | Tong et al., 2014 | China | Asian | TaqMan | PB | 570/673 | 103/308/159 | 129/307/237 | ALL | 14 | 0.11 |
65 | Wang N. et al., 2014 | China | Asian | PCR-LDR | PB | 597/597 | 128/307/162 | 145/298/154 | ESCC | 13 | 0.97 |
66 | Zhou et al., 2014 | China | Asian | PCR-RFLP | HB | 266/281 | 93/139/34 | 66/160/55 | HCC | 10 | 0.02 |
67 | Ahn et al., 2013 | South Korea | Asian | PCR-RFLP | PB | 461/447 | 100/242/119 | 87/232/128 | GC | 12 | 0.35 |
68 | Han et al., 2013 | China | Asian | TaqMan | PB | 1,017/1,009 | 207/505/305 | 220/485/304 | HCC | 10 | 0.33 |
69 | Hu et al., 2013 | China | Asian | Sequencing | HB | 680/690 | 185/314/181 | 138/342/210 | Glioma | 14 | 0.98 |
70 | Liu et al., 2013 | Taiwan | Asian | PCR-RFLP | NA | 315/92 | 64/147/104 | 26/36/30 | OC | 6 | 0.055 |
71 | Lv et al., 2013 | China | Asian | PCR-RFLP | PB | 347/531 | 10/223/114 | 109/331/91 | CRC | 10 | 1.5e−8 |
72 | Ma et al., 2013 | China | Asian | Mass-ARRAY | PB | 190/187 | 44/92/54 | 49/79/59 | BC | 11 | 0.047 |
73 | Min et al., 2012 | South Korea | Asian | PCR-RFLP | PB | 446/502 | 120/201/125 | 100/254/148 | CRC | 12 | 0.68 |
74 | Pavlakis et al., 2013 | Greece | Caucasian | PCR-RFLP | PB | 93/122 | 12/33/48 | 14/58/50 | PNC | 10 | 0.75 |
75 | Umar et al., 2013 | India | Asian | PCR-RFLP | PB | 289/309 | 146/121/22 | 171/122/16 | ESCC | 12 | 0.39 |
76 | Vinci et al., 2013 | Italy | Caucasian | HRMA | HB | 160/178 | 62/86/12 | 83/84/11 | CRC | 9 | 0.11 |
77 | Wang et al., 2013 | China | Asian | TaqMan | HB | 1,689/1,946 | 319/851/519 | 482/940/524 | GC | 10 | 0.14 |
78 | Wei et al., 2013 | China | Asian | Mass-ARRAY | HB | 367/370 | 65/196/106 | 87/170/113 | ESCC | 12 | 0.16 |
79 | Zhang et al., 2013 | China | Asian | Mass-ARRAY | PB | 996/995 | 214/488/294 | 165/502/328 | HCC | 10 | 0.26 |
80 | Alshatwi et al., 2012 | Saudi Arabia | Asian | TaqMan | HB | 100/100 | 35/63/2 | 46/50/4 | BC | 4 | 0.051 |
81 | Chen et al., 2012 | China | Asian | PCR-LDR | HB | 126/407 | 27/64/35 | 94/206/107 | CRC | 12 | 0.84 |
82 | Chu et al., 2012 | Taiwan | Asian | PCR-RFLP | PB | 470/425 | 57/277/136 | 87/206/132 | OC | 11 | 0.68 |
83 | Hezova et al., 2012 | Czech Republic | Caucasian | TaqMan | PB | 197/212 | 82/89/26 | 87/103/22 | CRC | 9 | 0.34 |
84 | Kim et al., 2012 | South Korea | Asian | PCR-RFLP | PB | 159/201 | 34/84/41 | 45/107/49 | HCC | 11 | 0.41 |
85 | Linhares et al., 2012 | Brazil | Mixed | TaqMan | HB | 388/388 | 94/177/117 | 127/165/96 | BC | 7 | 0.005 |
86 | Zhang M. et al., 2012 | China | Asian | PCR-RFLP | PB | 248/243 | 11/89/148 | 17/93/133 | BC | 13 | 0.96 |
87 | Zhu et al., 2012 | China | Asian | TaqMan | HB | 573/588 | 140/303/130 | 121/295/172 | CRC | 12 | 0.83 |
88 | Akkiz et al., 2011 | Turkey | Asian | PCR-RFLP | HB | 185/185 | 77/86/22 | 58/87/40 | HCC | 12 | 0.56 |
89 | George et al., 2011 | India | Asian | PCR-RFLP | PB | 159/230 | 55/101/3 | 106/114/10 | PC | 10 | 0.003 |
90 | Hong et al., 2011 | South Korea | Asian | TaqMan | HB | 406/428 | 86/224/96 | 96/198/134 | LC | 12 | 0.18 |
91 | Jedlinski et al., 2011 | Australia | Caucasian | PCR-RFLP | PB | 187/171 | 68/86/33 | 58/82/31 | BC | 9 | 0.91 |
92 | Mittal et al., 2011 | India | Asian | PCR-RFLP | HB | 212/250 | 76/131/5 | 109/127/14 | BlC | 10 | 0.004 |
93 | Vinci et al., 2011 | Italy | Caucasian | HRMA | HB | 101/129 | 35/54/12 | 58/61/10 | LC | 9 | 0.34 |
94 | Zhan et al., 2011 | China | Asian | PCR-RFLP | HB | 252/543 | 68/128/56 | 113/267/163 | CRC | 11 | 0.89 |
95 | Catucci et al., 2010 | Italy | Caucasian | TaqMan | PB | 751/1243 | 334/330/87 | 532/550/161 | BC | 11 | 0.33 |
Germany | Caucasian | TaqMan | PB | 1,101/1,496 | 432/512/157 | 584/696/216 | BC | 11 | 0.74 | ||
96 | Christensen et al., 2010 | USA | Caucasian | TaqMan | PB | 484/555 | 182/224/78 | 188/279/88 | HNSCC | 14 | 0.39 |
97 | Dou et al., 2010 | China | Asian | PCR-LDR | HB | 643/656 | 111/343/189 | 143/305/208 | Glioma | 11 | 0.13 |
98 | Li et al., 2010 | China | Asian | PCR-RFLP | HB | 310/222 | 78/150/82 | 42/102/78 | HCC | 9 | 0.46 |
99 | Liu et al., 2010 | USA | Caucasian | PCR-RFLP | HB | 1,109/1,130 | 350/565/194 | 383/545/202 | HNSCC | 13 | 0.77 |
100 | Okubo et al., 2010 | Japan | Asian | PCR-RFLP | HB | 552/697 | 105/281/166 | 124/350/223 | GC | 11 | 0.54 |
101 | Peng et al., 2010 | China | Asian | PCR-RFLP | HB | 213/213 | 76/94/43 | 56/107/50 | GC | 10 | 0.96 |
102 | Qi et al., 2010 | China | Asian | PCR-LDR | PB | 361/391 | 82/179/100 | 92/197/102 | HCC | 10 | 0.92 |
103 | Srivastava et al., 2010 | India | Asian | PCR-RFLP | PB | 230/230 | 119/95/16 | 136/75/19 | GBC | 12 | 0.09 |
104 | Wang et al., 2010 | China | Asian | SNaPshot | HB | 458/489 | 148/262/48 | 128/250/111 | ESCC | 11 | 0.64 |
105 | Kim et al., 2010 | Korea | Asian | PCR-RFLP | PB | 654/640 | 187/305,162 | 155/300/185 | LC | 14 | 0.14 |
106 | Hoffman et al., 2009 | USA | Caucasian | Mass-ARRAY | HB | 426/466 | 181/209/36 | 166/229/71 | BC | 9 | 0.63 |
107 | Hu et al., 2009 | China | Asian | PCR-RFLP | PB | 1,009/1,093 | 239/483/287 | 218/517/358 | BC | 14 | 0.22 |
108 | Tian et al., 2009 | China | Asian | PCR-RFLP | PB | 1,058/1,035 | 253/512/293 | 209/519/307 | LC | 14 | 0.73 |
109 | Horikawa et al., 2008 | USA | Caucasian | Capillary electrophoresis | PB | 276/277 | 105/126/45 | 101/117/59 | RCC | 11 | 0.03 |
110 | Yang et al., 2008 | USA | Caucasian | Capillary electrophoresis | PB | 736/731 | 255/348/133 | 257/342/132 | BlC | 13 | 0.35 |
Genotype distributions are sorted as CC/CT/TT.
Genotype distributions are sorted as CC/CT/TT. PB, population-based design; HB, hospital-based design; NC, Not clear; ALL, Acute myeloblastic leukemia; BC, Breast cancer; BlC, Bladder cancer; CLL, Chronic lymphoblastic leukemia; CRC, Colorectal cancer; CSCC, Cervical Squamous Cell Carcinoma; ESCC, Esophageal squamous cell carcinoma; GBC, Gallbladder carcinoma; GC, Gastric cancer; HCC, Hepatocellular carcinoma; HNSCC, Head and neck squamous cell carcinoma; LC, Lung cancer; NB, Neuroblastoma; NC, Nasopharyngeal carcinoma; NHL, non-Hodgkin lymphoma; OC, Oral cancer; OvC, Ovarian cancer; PC, Prostate cancer; PNC, Pancreatic cancer; RCC, Renal cell carcinoma.